Our December Trials Sites Snapshot provides easily digestible information for owner-operators, including: Founders Advisors’ market commentary Public market metrics/KPIs Recent M&A activity Recommended reading Access the report here and reach out to Courtney Davies or Michael White if you would like to have a more individualized conversation about market dynamics and valuation drivers for your…
Our Clinical Trials Site Value Driver Report highlights the key factors that drive valuation for independent clinical trials site businesses. It breaks down the most important qualitative and quantitative value drivers: Qualitative Drivers: depth and pipeline of principal investigators; a reliable patient enrollment strategy; a clear therapeutic-area strategy (either niche or diversified); a strong, energetic management team; independence from…
Our latest webinar offered a clear, straightforward overview of what it means for healthcare and life sciences companies to partner with private equity. Led by Michael White, the session walked through what PE buyers look for, how businesses are valued, and what business owners should expect in a sale or partnership process. During the webinar,…
Our latest webinar offered insight into how the advent of digital marketing, coupled with the ever decreasing cost of data analytics, has enabled even small businesses to design and execute elegant, effective marketing strategies. For the right trials site, digital marketing can be a powerful tool for patient recruitment. During the webinar, Michael White gets insight…
Our October Trials Sites Snapshot provides easily digestible information for owner-operators, including: Founders Advisors’ market commentary Public market metrics/KPIs Recent M&A activity Recommended reading Access the report here and reach out to Courtney Davies or Michael White if you would like to have a more individualized conversation about market dynamics and valuation drivers for your…
The pharma services sector continues to show strong momentum through 2025 as demand for outsourced solutions accelerates across drug development, manufacturing, and commercialization. In our latest Pharma Services Market Update, we break down key trends shaping the space and where investors are finding the most attractive opportunities. Key Highlights: Sustained growth across CDMO and CRO segments: Pharma…